Laddar...
HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease
In vitro and animal studies continue to elucidate the mechanisms of fibrosis and have led to advancements in treatment for idiopathic pulmonary fibrosis and cirrhosis, but the search for treatments for renal fibrosis has been more disappointing. Here, we will discuss homeodomain-interacting-protein...
Sparad:
| I publikationen: | Front Physiol |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Frontiers Media S.A.
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4411988/ https://ncbi.nlm.nih.gov/pubmed/25972814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphys.2015.00132 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|